Skip to content

Roivant Sciences ROIV Cash Flow Statement

Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24
-$313.7M-88.9%-$166.04M+25.7%-$223.36M+11.5%-$252.38M-314%
$638K-7.7%$691K-25.0%$921K-16.1%$1.1M-22.9%$1.43M-51.2%
$77.17M-26.5%$105M+28.3%$81.82M-0.4%$82.18M-1.6%$83.49M-0.2%
-$163.82M+16.6%-$196.48M-5.8%-$185.66M+9.2%-$204.38M-18.4%-$172.57M+16.7%
$1.26M$7.85M+94.5%$4.04M+398%$811K-55.6%
-$1.09B
$208.29M-29.5%$295.45M+21.4%
$328.19M-$187.77M-6.0%-$177.15M+35.1%
-$57.79M-$1.45M+99.9%-$1.48B
-$165.08M+13.8%-$191.55M+1.0%-$193.51M+7.2%-$208.42M-20.2%-$173.38M+17.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Roivant Sciences generate?
Roivant Sciences (ROIV) generated -$750.3M in operating cash flow over the trailing twelve months.
What is Roivant Sciences's free cash flow?
After $14.0M of capital expenditures, Roivant Sciences's free cash flow was -$758.6M over the trailing twelve months, up 10.1% year over year.
Where does Roivant Sciences's cash flow data come from?
Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.